About 11 results found for searched term "73-05-2" (0.053 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M3267 | Nepicastat | Others |
| SYN117, RS-25560-197 | ||
| Nepicastat is a dopamine beta-hydroxylase inhibitor with IC50 of 8.5 ±0.8 and 9.0 ±0.8 nM for bovine and human, respectively. | ||
| M6420 | AIM-100 | Others |
| AIM100 | ||
| AIM-100 is a potent and selective Ack1 (TNK2) inhibitor (IC50 = 22 nM). | ||
| M7660 | Omapatrilat | Neprilysin (NEP) |
| BMS-186716 | ||
| Omapatrilat is a vasopeptidase inhibitor, a dual metalloprotease inhibitor of neutral endopeptidase (NEP, neprilysin) and angiotensin converting enzyme (ACE). | ||
| M8023 | Phentolamine hydrochloride | Adrenergic Receptor |
| PHE hydrochloride | ||
| α-adrenoceptor antagonist; peripheral vasodilator. | ||
| M14810 | Elabela(19-32) | Apelin Receptor |
| Elabela(19-32) is an active fragment of ELABELA (ELA) that binds to apelin receptor (APJ). Elabela(19-32) activates the Gαi1 and β-arrestin-2 signaling pathways with EC50s of 8.6 nM and 166 nM. Elabela(19-32) induces receptor internalization and reduces arterial pressure, exerts positive inotropic effects on the heart. | ||
| M14811 | Elabela(19-32) TFA | Apelin Receptor |
| Elabela(19-32) TFA is an active fragment of ELABELA (ELA) that binds to apelin receptor (APJ). Elabela(19-32) TFA activates the Gαi1 and β-arrestin-2 signaling pathways with EC50s of 8.6 nM and 166 nM. Elabela(19-32) TFA induces receptor internalization and reduces arterial pressure, exerts positive inotropic effects on the heart. | ||
| M24545 | Samalizumab | Others |
| ALXN 6000 | ||
| Samalizumab (ALXN 6000) is a humanized monoclonal antibody that specifically binds to CD200 and blocks its ligation to the CD200 receptor (CD200R). Samalizumab can be used for multiple myeloma and B-cell chronic lymphocytic leukemia research. | ||
| M29330 | Fluorescein diphosphate tetraammonium | Fluorescent Dye |
| Fluorescein diphosphate tetraammonium is a fluorescent dye, it can be used as a fluorogenic substrate and generats fluorescein as a fluorescent product. | ||
| M30016 | CCPA | Nucleoside Antimetabolite/Analog |
| 2-Chloro-N6-cyclopentyladenosine | ||
| CCPA (2-Chloro-N6-cyclopentyladenosine) is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc. | ||
| M30469 | Facinicline hydrochloride | AChR/AChE |
| RG3487 hydrochloride | ||
| Facinicline hydrochloride (RG3487 hydrochloride) is an orally active nicotinic α7 receptor partial agonist, with a Ki of 6 nM for α7 human nAChR. Facinicline hydrochloride (RG3487 hydrochloride) improves cognition and sensorimotor gating in rodents. Facinicline hydrochloride (RG3487 hydrochloride) shows high affinity (antagonist) to 5-HT3Rs with a Ki value of 1.2 nM. | ||
| M58475 | DDR2-IN-1 | Discoidin Domain Receptor |
| DDR2-IN-1 is potent DDR2 inhibitor with an IC50 of 26 nM. DDR2-IN-1 can be used for osteoarthritis research. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
